Sponsor study identifier
interventional
8
1 country
1
Study Start
September 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2005
Actual (reported)Study Completion
December 2005
Actual (reported)An open labelled trial of Kineret (anakinra) induction therapy (100mg./day) in over a four week period in the treatment of Familial Cold Urticaria. Familial Cold Urticaria (FCU) is a rare autosomal dominant condition manifesting symptoms triggered by exposure to cold and variable in expression. Currently there is no standard reliable agent available for the treatment of patients with FCU.This study will evaluate the efficacy of Kineret (anakinra), an interleukin 1 receptor antagonist in induction and maintenance therapy in patients with FCU.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2005
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2005
Date type not reportedThis date has not been verified as actual or estimated.
September 21, 2005
Actual (reported)September 22, 2005
Actual (reported)December 2005
Actual (reported)December 2005
Actual (reported)To determine the efficacy of kineret (anakinra) 100mg./day in subjects with familial cold urticaria.
Eight weeks
To demonstrate the use of C-Reactive Protein (CRP) and Serum Amyloid A Protein (SAA) levels as objective laboratory indicators of effective treatment and to compare the results of two different laboratory methods for the estimation of CRP
Eight weeks
Kineret (anakinra 100 mg. s/c daily x 4 weeks
Queen Elizabeth Health Sciences Centre
Halifax, Nova Scotia, B3H 1V7, Canada
Laura A. Finlayson MD FRCPC
Nova Scotia Health Authority
First Submitted
September 21, 2005
First Posted
September 22, 2005
Study Start
September 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2005
Actual (reported)Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients
Contact the study team to confirm eligibility.
Study Completion
December 2005
Actual (reported)Last Updated
November 8, 2022
Record last verified: 2008-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: